SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-019955
Filing Date
2022-02-11
Accepted
2022-02-11 09:15:43
Documents
1
Period of Report
2022-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm226323d1_4.html 4  
1 FORM 4 tm226323d1_4.xml 4 3958
  Complete submission text file 0001104659-22-019955.txt   5280
Mailing Address 750 LEXINGTON AVE 20TH FL NEW YORK NY 10022
Business Address
BENTSUR RON (Reporting) CIK: 0001251213 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41264 | Film No.: 22617060

Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Issuer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences